Kairos Biotech is an early stage company focusing on proprietary small molecule discovery applied to diagnostics and immunotherapy.
Kairos Biotech has raised $1.1M in total funding. The most recent round was Seed. The last funding was announced in February 2023.
Kairos Biotech's investors include EchiumBio Holding BV.
Kairos Biotech is headquartered in Denbigh, United Kingdom.
Kairos Biotech is an early stage company focusing on proprietary small molecule discovery applied to diagnostics and immunotherapy.
Kairos Biotech is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Kairos Biotech — Funding & Investors." VCBacked, February 1, 2023, https://www.vcbacked.co/company/kairos-biotech. Accessed August 18, 2026.
VCBacked. (2023). Kairos Biotech — Funding & Investors. Retrieved August 18, 2026, from https://www.vcbacked.co/company/kairos-biotech
{{cite web |title=Kairos Biotech — Funding & Investors |url=https://www.vcbacked.co/company/kairos-biotech |website=VCBacked |access-date=August 18, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated